Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Abrdn Life Sciences Investors Shares Of Beneficial Interest | HQL | Aug 30, 2024 | 15.13 | -0.46 |
Abrdn National Municipal Income Fund | VFL | Aug 30, 2024 | 10.91 | +0.28 |
Abrdn Total Dynamic Dividend Fund | AOD | Aug 30, 2024 | 8.95 | +0.45 |
Abrdn World Healthcare Fund Shares Of Beneficial Interest | THW | Aug 30, 2024 | 13.29 | +0.45 |
Absci | ABSI | Aug 30, 2024 | 4.40 | +2.33 |
ABVC Biopharma | ABVC | Aug 30, 2024 | 0.68 | -1.37 |
Ac Immune SA | ACIU | Aug 30, 2024 | 3.23 | 0.00 |
Acacia Research | ACTG | Aug 30, 2024 | 4.81 | +0.42 |
Academy Sports and Outdoors | ASO | Aug 30, 2024 | 55.48 | +0.34 |
Acadia Healthcare | ACHC | Aug 30, 2024 | 81.93 | +1.34 |
Acadia Pharmaceuticals | ACAD | Aug 30, 2024 | 16.58 | +1.59 |
Acadia Realty Trust | AKR | Aug 30, 2024 | 22.51 | +0.27 |
Acasti Pharma A | ACST | Aug 30, 2024 | 2.62 | -0.76 |
Accel Entertainment | ACEL | Aug 30, 2024 | 11.66 | -0.34 |
Accelerate Diagnostics | AXDX | Aug 30, 2024 | 2.00 | +4.64 |
Accenture A | ACN | Aug 30, 2024 | 341.95 | +0.51 |
Acco Brands | ACCO | Aug 30, 2024 | 5.48 | +0.55 |
Accolade | ACCD | Aug 30, 2024 | 4.34 | +0.70 |
Accuray | ARAY | Aug 30, 2024 | 2.18 | 0.00 |
Acelyrin | SLRN | Aug 30, 2024 | 4.78 | -0.62 |
Achieve Life Sciences | ACHV | Aug 30, 2024 | 4.39 | -0.90 |
Achilles Therapeutics ADR | ACHL | Aug 30, 2024 | 0.72 | -2.23 |
ACI Worldwide | ACIW | Aug 30, 2024 | 50.36 | +1.39 |
Aclarion | ACON | Aug 30, 2024 | 0.21 | -3.46 |
Aclaris Therapeutics | ACRS | Aug 30, 2024 | 1.18 | +0.85 |
ACM Research A | ACMR | Aug 30, 2024 | 18.04 | +1.46 |
Acme United | ACU | Aug 30, 2024 | 44.09 | +0.62 |
ACNB | ACNB | Aug 30, 2024 | 42.02 | +0.05 |
ACRES Commercial Realty | ACR | Aug 30, 2024 | 15.45 | -1.90 |
ACRES Commercial Realty C Pref | ACR-C | Aug 30, 2024 | 24.90 | -0.04 |
|
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.